Hong Kong Pharmaceuticals and Healthcare Report Q4 2015

Date: August 19, 2015
Pages: 113
Price:
US$ 1,295.00
Publisher: BMI RESEARCH
Report type: Strategic Report
Delivery: Download
ID: H1C2EC1410FEN
Leaflet:

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI View: Hong Kong's strong reliance on the public health sector will continue to place a strain on the government's budget. This is especially critical in light of its ageing population. We maintain that health expenditure in Hong Kong will continue to shift towards private expenditure and the private sector.

Headline Expenditure Projections
  • Pharmaceuticals: HKD12.07bn (USD1.56bn) in 2014 to HKD12.96bn (USD1.67bn) in 2015; +7.2% in local currency and 7.1% US dollars terms. Forecast unchanged from previous quarter.
  • Healthcare: HKD132.71bn (USD17.11bn) in 2014 to HKD143.45bn (USD18.46bn) in 2015; +8.1% in local currency and 7.9% in US dollars terms. Forecast unchanged from previous quarter.
BMI Industry View
SWOT
Political SWOT
Economic SWOT
Operational Risk SWOT
Industry Forecast
Pharmaceutical Market Forecast
  Table: Pharmaceutical Sales, Historical Data And Forecasts (Hong Kong 2011-2019)
Healthcare Market Forecast
  Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2011-2019)
  Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2011-2019)
  Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2011-2019)
Prescription Drug Market Forecast
  Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2011-2019)
Patented Drug Market Forecast
  Table: Patented Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2011-2019)
Generic Drug Market Forecast
  Table: Generic Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2011-2019)
OTC Medicine Market Forecast
  Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Hong Kong 2011-2019)
Pharmaceutical Trade Forecast
  Table: Pharmaceutical Trade Data And Forecasts (Hong Kong 2013-2019)
  Table: Pharmaceutical Trade Data And Forecasts local currency (Hong Kong 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
  Table: Economic Activity (Hong Kong 2010-2019)
Industry Risk Reward Index
Asia Pacific Risk/Reward - Q4 2015
Hong Kong Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
  Table: Top Causes Of Deaths In Hong Kong
Healthcare Sector
  Table: Healthcare Resources (Hong Kong 2009-2014)
  Table: Healthcare Personnel (Hong Kong 2009-2014)
  Table: Healthcare Activity (Hong Kong 2009-2014)
Healthcare Financing
Biotechnology
Clinical Trials
Regulatory Development
Regulatory Regime
  Table: Processed Applications
Regulatory Developments
Pharmaceutical Trade Regulations
Intellectual Property Issues
Counterfeit Drugs
Pricing And Reimbursement Regime
  Table: Number Of Drugs In Drug Formulary
Competitive Landscape
Pharmaceutical Industry
Traditional Chinese Medicine
Industry Developments
Pharmaceutical Supply Chain
Retail Pharmacy Sector
Company Profile
Wuyi International Pharmaceutical
CK Life Sciences
South Asia Pharmamedic
Vida Laboratories
GlaxoSmithKline
Pfizer
Sanofi
Merck & Co
Novartis
Demographic Forecast
  Table: Population Headline Indicators (Hong Kong 1990-2025)
  Table: Key Population Ratios (Hong Kong 1990-2025)
  Table: Urban/Rural Population And Life Expectancy (Hong Kong 1990-2025)
  Table: Population By Age Group (Hong Kong 1990-2025)
  Table: Population By Age Group % (Hong Kong 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
  Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings
Skip to top


Hong Kong Pharmaceuticals and Healthcare Report Q1 2015 US$ 1,295.00 Nov, 2014 · 113 pages
Hong Kong Pharmaceuticals and Healthcare Report Q2 2015 US$ 1,295.00 Feb, 2015 · 118 pages
Hong Kong Pharmaceuticals and Healthcare Report Q3 2015 US$ 1,295.00 May, 2015 · 113 pages

Ask Your Question

Hong Kong Pharmaceuticals and Healthcare Report Q4 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: